Abstract
The effects of interleukin-12 on autoimmune diabetes in nonobese diabetic mice was examined. IL-12 was given, intraperitoneally, to NOD females in two different treatment protocols: three times a week, for 2 weeks beginning at 9 weeks of age and a single weekly injection, for 15 weeks, beginning at 9 weeks of age. A significant decrease in diabetes incidence was observed with multidose/short-term IL-12 treatment. Age of disease onset, however, was unchanged. Weekly administration of IL-12 was more effective in preventing onset of diabetes. Only 20% of female NOD mice become diabetic by 30 weeks of age, with a later age of onset. In spite of the decrease in diabetes incidence, no differences were seen in islet histology with treated mice compared to controls. Furthermore, IL-12 treatment of recipient mice did not prevent induction of diabetes using spleen cells from diabetic mice in adoptive transfer experiments. These observations are in contrast to reported data in which treatment of NOD mice with daily doses of IL-12 exacerbated disease incidence and hastened diabetes onset.
References
Jan 1, 1992·Advances in Immunology·H Kikutani, S Makino
Apr 1, 1991·Journal of Autoimmunity·M Debray-SachsJ F Bach
May 1, 1990·Diabetes·M W SadelainB Singh
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·C O JacobH Acha-Orbea
May 1, 1989·The Journal of Experimental Medicine·C BoitardJ F Bach
Dec 1, 1989·Journal of Autoimmunity·D V SerrezeE H Leiter
Dec 1, 1989·Diabetes·E P ReichC A Janeway
Oct 1, 1989·The Journal of Clinical Investigation·J SatohT Oteki
Oct 1, 1987·The Journal of Experimental Medicine·A BendelacJ F Bach
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·X D YangH O McDevitt
Aug 1, 1993·European Journal of Immunology·B NaumeA Sundan
Sep 1, 1993·The Journal of Experimental Medicine·V Kumar, E E Sercarz
Nov 4, 1993·Nature·D L KaufmanP V Lehmann
Feb 1, 1995·The Journal of Experimental Medicine·S TrembleauL Adorini
Sep 1, 1994·The Journal of Experimental Medicine·X D YangH O McDevitt
Apr 1, 1993·The Journal of Experimental Medicine·R ManettiS Romagnani
Apr 23, 1993·Science·P Scott
Apr 23, 1993·Science·C S HsiehK M Murphy
Jun 25, 1993·Science·T A StewartN J MacLachlan
Aug 1, 1993·European Journal of Immunology·T GermannE Rüde
May 1, 1994·Clinical Immunology and Immunopathology·K J PennlineM Monahan
Nov 4, 1993·Nature·R TischH O McDevitt
Jul 1, 1993·The Journal of Experimental Medicine·M J RapoportT L Delovitch
Citations
Jun 26, 1999·European Journal of Immunology·P ZacconeA Cooke
Jul 31, 1998·Clinical Immunology and Immunopathology·R R Caspi
Oct 12, 2012·Diabetologia·D A Taylor-FishwickJ L Nadler
Jan 13, 2000·Current Opinion in Immunology·M Falcone, N Sarvetnick
May 10, 2003·Trends in Immunology·Ursula GrohmannPaolo Puccetti
Aug 14, 1999·Immunology·F NicolettiP L Meroni
Sep 30, 2000·Immunology·J LiuX Wang
Jan 20, 1999·The Journal of Experimental Medicine·T K TarrantR R Caspi
Aug 28, 1998·Human Gene Therapy·Y NittaJ Miyazaki
Jun 28, 2002·Diabetes·Abdoreza Davoodi-SemiromiJin-Xiong She
Sep 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F NicolettiP Meroni
Apr 26, 2002·Gene Therapy·O AdachiJ Miyazaki
Mar 27, 2003·Nature Reviews. Immunology·S Brian Wilson, Terry L Delovitch
Oct 18, 2019·Human Genetics·Marjut SalokannelKaroliina Snell
Jun 24, 2004·American Journal of Reproductive Immunology : AJRI·Michela ReinaErminio Giavini
Nov 25, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yoichi OikawaTakao Saruta
Dec 22, 1999·Human Reproduction·E SomiglianaP Panina-Bordignon
Jul 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·K ChenH Braley-Mullen
Mar 11, 2008·Cytokine·Karla Priscila VieiraRicardo de Lima Zollner